MAM
iProspect India bags Bombay Realty’s digital account
MUMBAI: iProspect India, the digital performance agency from Denstu Aegis Network, has won the digital duties for Bombay Realty, the real estate venture from the Wadia Group, following a multi-agency pitch.
As part of the mandate, the agency will service the account from its Mumbai office and will offer its 360-degree digital service to the client including search engine optimisation (SEO), organic social, Object-relational mapping (ORM), paid media and display media.
Commenting on the account win, Rubeena Singh, CEO, iProspect India said, “It is great to see one more client from this important sector come on board. We are extremely happy to help Bombay Realty achieve its digital goals through our expertise.” It is pertinent to note here that the agency also services many other real estate clients such as the Lodha Group and Xrbia Developers.
Speaking on the association, Kulwant Khurana, Vice President – Sales & Marketing, Bombay Realty said, “Today’s customers are enormously digital-savvy and we need to be where the customer is. Island City Center is an ultra-luxury project, and with iProspect, we hope to reach the right customer and strengthen our digital footprint.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
